The search found 4101 results.
Blog
Ensure EPCS success by following these six comprehensive steps. Deploying Electronic Prescribing of Controlled Substances shouldn't be a headache.
Press
Lexington, Mass. — December 18, 2014— Imprivata® (NYSE: IMPR) today announced that members of management will participate in the 33rd Annual J.P. Morgan Healthcare Conference.
Omar Hussain, President and CEO, and Jeff Kalowski, Chief Financial Officer, will present at the conference in San Francisco, California on Wednesday, January 14th at 3:30 PM PST.
An audio webcast of the presentation will be available live and archived on Imprivata’s investor relations website at http://investor.imprivata.com
News
The secure communication platform will allow for mobile and desktop messaging across the Medical Center’s network of four hospitals
Blog
2014 was an important year for combating prescription drug abuse. Learn how 2015 is going to be even more momentous.
Press
Lexington, Mass. — January 12, 2015— Imprivata® (NYSE: IMPR) today announced that it expects its fourth quarter 2014 revenue to exceed the upper end of its previously announced guidance range of $26 to $27 million. During the quarter, the company continued to invest in sales and marketing, and in the development of new solutions that will leverage Imprivata’s authentication platform and drive long-term growth.